Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2024 Apr 16:S0007-4551(24)00119-X. doi: 10.1016/j.bulcan.2024.02.013. Online ahead of print.ABSTRACTChimeric antigen receptor T cell (CAR-T cell) therapy has become a standard-of-care for several hematological and a promising treatment for solid malignancies or for selected non-malignant autoimmune disorders. Hematological complications following this treatment are very common with the majority of patients experiencing at least one cytopenia after CAR-T cell injections. The management of these adverse events is not standardized and represents an area of active research and unmet clinical needs. This harmonizat...
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Tamim Alsuliman Clotilde Aubrun Jacques Olivier Bay Yves Beguin Camille Bigenwald Eolia Brissot Yves Chalandon Patrice Chevallier Simona Pagliuca L éonardo Magro Micha Srour Source Type: research
Epcoritamab - relapsed or refractory large diffuse B cells lymphoma after two or more lines of systemic therapy
Bull Cancer. 2024 Apr 16:S0007-4551(24)00117-6. doi: 10.1016/j.bulcan.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38631985 | DOI:10.1016/j.bulcan.2024.02.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Hedi Bensaber Victoria Cacheux Source Type: research
Onco'sport testing by patients: Lived experience of patients with cancer practicing adapted physical activity as part of the Onco'sport program, a qualitative study
CONCLUSION: An APA program like Onco'sport is often the cause of a return to physical activity in patients, brings overall well-being and changes lifestyle habits. It seems important to promote physical activity to patients but also to the general population, given the benefits. This promotion involves easier access to this type of supervised program, financial support and better training of health professionals.PMID:38631986 | DOI:10.1016/j.bulcan.2024.02.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Lo ïc Pagès Estelle Gouin-Barr é C éline Bourgier Source Type: research
Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2024 Apr 16:S0007-4551(24)00119-X. doi: 10.1016/j.bulcan.2024.02.013. Online ahead of print.ABSTRACTChimeric antigen receptor T cell (CAR-T cell) therapy has become a standard-of-care for several hematological and a promising treatment for solid malignancies or for selected non-malignant autoimmune disorders. Hematological complications following this treatment are very common with the majority of patients experiencing at least one cytopenia after CAR-T cell injections. The management of these adverse events is not standardized and represents an area of active research and unmet clinical needs. This harmonizat...
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Tamim Alsuliman Clotilde Aubrun Jacques Olivier Bay Yves Beguin Camille Bigenwald Eolia Brissot Yves Chalandon Patrice Chevallier Simona Pagliuca L éonardo Magro Micha Srour Source Type: research
Epcoritamab - relapsed or refractory large diffuse B cells lymphoma after two or more lines of systemic therapy
Bull Cancer. 2024 Apr 16:S0007-4551(24)00117-6. doi: 10.1016/j.bulcan.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38631985 | DOI:10.1016/j.bulcan.2024.02.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Hedi Bensaber Victoria Cacheux Source Type: research
Onco'sport testing by patients: Lived experience of patients with cancer practicing adapted physical activity as part of the Onco'sport program, a qualitative study
CONCLUSION: An APA program like Onco'sport is often the cause of a return to physical activity in patients, brings overall well-being and changes lifestyle habits. It seems important to promote physical activity to patients but also to the general population, given the benefits. This promotion involves easier access to this type of supervised program, financial support and better training of health professionals.PMID:38631986 | DOI:10.1016/j.bulcan.2024.02.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Lo ïc Pagès Estelle Gouin-Barr é C éline Bourgier Source Type: research
Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2024 Apr 16:S0007-4551(24)00119-X. doi: 10.1016/j.bulcan.2024.02.013. Online ahead of print.ABSTRACTChimeric antigen receptor T cell (CAR-T cell) therapy has become a standard-of-care for several hematological and a promising treatment for solid malignancies or for selected non-malignant autoimmune disorders. Hematological complications following this treatment are very common with the majority of patients experiencing at least one cytopenia after CAR-T cell injections. The management of these adverse events is not standardized and represents an area of active research and unmet clinical needs. This harmonizat...
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Tamim Alsuliman Clotilde Aubrun Jacques Olivier Bay Yves Beguin Camille Bigenwald Eolia Brissot Yves Chalandon Patrice Chevallier Simona Pagliuca L éonardo Magro Micha Srour Source Type: research
Epcoritamab - relapsed or refractory large diffuse B cells lymphoma after two or more lines of systemic therapy
Bull Cancer. 2024 Apr 16:S0007-4551(24)00117-6. doi: 10.1016/j.bulcan.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38631985 | DOI:10.1016/j.bulcan.2024.02.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Hedi Bensaber Victoria Cacheux Source Type: research
Onco'sport testing by patients: Lived experience of patients with cancer practicing adapted physical activity as part of the Onco'sport program, a qualitative study
CONCLUSION: An APA program like Onco'sport is often the cause of a return to physical activity in patients, brings overall well-being and changes lifestyle habits. It seems important to promote physical activity to patients but also to the general population, given the benefits. This promotion involves easier access to this type of supervised program, financial support and better training of health professionals.PMID:38631986 | DOI:10.1016/j.bulcan.2024.02.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Lo ïc Pagès Estelle Gouin-Barr é C éline Bourgier Source Type: research
Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2024 Apr 16:S0007-4551(24)00119-X. doi: 10.1016/j.bulcan.2024.02.013. Online ahead of print.ABSTRACTChimeric antigen receptor T cell (CAR-T cell) therapy has become a standard-of-care for several hematological and a promising treatment for solid malignancies or for selected non-malignant autoimmune disorders. Hematological complications following this treatment are very common with the majority of patients experiencing at least one cytopenia after CAR-T cell injections. The management of these adverse events is not standardized and represents an area of active research and unmet clinical needs. This harmonizat...
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Tamim Alsuliman Clotilde Aubrun Jacques Olivier Bay Yves Beguin Camille Bigenwald Eolia Brissot Yves Chalandon Patrice Chevallier Simona Pagliuca L éonardo Magro Micha Srour Source Type: research
Epcoritamab - relapsed or refractory large diffuse B cells lymphoma after two or more lines of systemic therapy
Bull Cancer. 2024 Apr 16:S0007-4551(24)00117-6. doi: 10.1016/j.bulcan.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38631985 | DOI:10.1016/j.bulcan.2024.02.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Hedi Bensaber Victoria Cacheux Source Type: research
Onco'sport testing by patients: Lived experience of patients with cancer practicing adapted physical activity as part of the Onco'sport program, a qualitative study
CONCLUSION: An APA program like Onco'sport is often the cause of a return to physical activity in patients, brings overall well-being and changes lifestyle habits. It seems important to promote physical activity to patients but also to the general population, given the benefits. This promotion involves easier access to this type of supervised program, financial support and better training of health professionals.PMID:38631986 | DOI:10.1016/j.bulcan.2024.02.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Lo ïc Pagès Estelle Gouin-Barr é C éline Bourgier Source Type: research
The PENTO protocol in medication-related osteonecrosis of the jaw: A single-center phase IIa trial
Bull Cancer. 2024 Apr 11:S0007-4551(24)00121-8. doi: 10.1016/j.bulcan.2024.02.015. Online ahead of print.NO ABSTRACTPMID:38609796 | DOI:10.1016/j.bulcan.2024.02.015 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 12, 2024 Category: Cancer & Oncology Authors: Adeline Dumur Esther Pages Jo ël Brie J érôme Laloze Julie Usseglio Source Type: research
The PENTO protocol in medication-related osteonecrosis of the jaw: A single-center phase IIa trial
Bull Cancer. 2024 Apr 11:S0007-4551(24)00121-8. doi: 10.1016/j.bulcan.2024.02.015. Online ahead of print.NO ABSTRACTPMID:38609796 | DOI:10.1016/j.bulcan.2024.02.015 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 12, 2024 Category: Cancer & Oncology Authors: Adeline Dumur Esther Pages Jo ël Brie J érôme Laloze Julie Usseglio Source Type: research
The PENTO protocol in medication-related osteonecrosis of the jaw: A single-center phase IIa trial
Bull Cancer. 2024 Apr 11:S0007-4551(24)00121-8. doi: 10.1016/j.bulcan.2024.02.015. Online ahead of print.NO ABSTRACTPMID:38609796 | DOI:10.1016/j.bulcan.2024.02.015 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - April 12, 2024 Category: Cancer & Oncology Authors: Adeline Dumur Esther Pages Jo ël Brie J érôme Laloze Julie Usseglio Source Type: research
